|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cui T, Srivastava AK, Han C, Yang L, Zhao
R, Zou N, Qu M, Duan W, Zhang X and Wang QE: XPC inhibits NSCLC
cell proliferation and migration by enhancing E-Cadherin
expression. Oncotarget. 6:10060–10072. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Osarogiagbon RU, Lin CC, Smeltzer MP and
Jemal A: Prevalence, prognostic implications, and survival
modulators of incompletely resected non-small cell lung cancer in
the U.S. national cancer data base. J Thorac Oncol. 11:e5–e16.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin JJ, Cardarella S, Lydon CA, Dahlberg
SE, Jackman DM, Jänne PA and Johnson BE: Five-year survival in
EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs.
J Thorac Oncol. 11:556–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parker NJ, Begley CG, Smith PJ and Fox RM:
Molecular cloning of a novel human gene (D11S4896E) at chromosomal
region 11p15.5. Genomics. 37:253–256. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johnstone LS, Graham SJ and Dziadek MA:
STIM proteins: Integrators of signalling pathways in development,
differentiation and disease. J Cell Mol Med. 14:1890–1903. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suyama E, Wadhwa R, Kaur K, Miyagishi M,
Kaul SC, Kawasaki H and Taira K: Identification of
metastasis-related genes in a mouse model using a library of
randomized ribozymes. J Biol Chem. 279:38083–38086. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang S, Zhang JJ and Huang XY: Orai1 and
STIM1 are critical for breast tumor cell migration and metastasis.
Cancer Cell. 15:124–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YF, Chiu WT, Chen YT, Lin PY, Huang
HJ, Chou CY, Chang HC, Tang MJ and Shen MR: Calcium store sensor
stromal-interaction molecule 1-dependent signaling plays an
important role in cervical cancer growth, migration, and
angiogenesis. Proc Natl Acad Sci USA. 108:15225–15230. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang N, Tang Y, Wang F, Zhang H, Xu D,
Shen Y, Sun S and Yang G: Blockade of store-operated Ca(2+) entry
inhibits hepatocarcinoma cell migration and invasion by regulating
focal adhesion turnover. Cancer Lett. 330:163–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Umemura M, Baljinnyam E, Feske S, De
Lorenzo MS, Xie LH, Feng X, Oda K, Makino A, Fujita T, Yokoyama U,
et al: Store-operated Ca2+ entry (SOCE) regulates
melanoma proliferation and cell migration. PLoS One. 9:e892922014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun J, Lu F, He H, Shen J, Messina J,
Mathew R, Wang D, Sarnaik AA, Chang WC, Kim M, et al: STIM1- and
Orai1-mediated Ca(2+) oscillation orchestrates invadopodium
formation and melanoma invasion. J Cell Biol. 207:535–548. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Z, Liu X, Feng B, Liu N, Wu Q, Han
Y, Nie Y, Wu K, Shi Y and Fan D: STIM1, a direct target of
microRNA-185, promotes tumor metastasis and is associated with poor
prognosis in colorectal cancer. Oncogene. 34:4808–4820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li W, Zhang M, Xu L, Lin D, Cai S and Zou
F: The apoptosis of non-small cell lung cancer induced by cisplatin
through modulation of STIM1. Exp Toxicol Pathol. 65:1073–1081.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Pan T, Wang H, Li L, Li J, Zhang C
and Yang H: Silencing of TGIF attenuates the tumorigenicity of A549
cells in vitro and in vivo. Tumour Biol. 37:12725–12730. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Travis W, Brambilla E, Muller-Hermelink H
and Harris C: World Health Organization classification of
tumoursPathology and Genetics Tumours of the Lung, Pleura, Thymus
and Heart. Lyon: IARC Press; 2004
|
|
17
|
Wang Y, Zhai W, Wang H, Xia X and Zhang C:
Benzo(a)pyrene promotes A549 cell migration and invasion through
up-regulating Twist. Arch Toxicol. 89:451–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American physiological
society. Physiologist. 39:199208. –211. 1996.PubMed/NCBI
|
|
19
|
Bratcher NA and Reinhard GR: Creative
implementation of 3Rs principles within industry programs: Beyond
regulations and guidelines. J Am Assoc Lab Anim Sci. 54:133–138.
2015.PubMed/NCBI
|
|
20
|
Hui L, Zhang S, Dong X, Tian D, Cui Z and
Qiu X: Prognostic significance of twist and N-cadherin expression
in NSCLC. PLoS One. 8:e621712013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bae GY, Choi SJ, Lee JS, Jo J, Lee J, Kim
J and Cha HJ: Loss of E-cadherin activates EGFR-MEK/ERK signaling,
which promotes invasion via the ZEB1/MMP2 axis in non-small cell
lung cancer. Oncotarget. 4:2512–2522. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gong L, Wu D, Zou J, Chen J, Chen L, Chen
Y, Ni C and Yuan H: Prognostic impact of serum and tissue MMP-9 in
non-small cell lung cancer: A systematic review and meta-analysis.
Oncotarget. 7:18458–18468. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang X, Han M, Han H, Wang B, Li S, Zhang
Z and Zhao W: Silencing snail suppresses tumor cell proliferation
and invasion by reversing epithelial-to-mesenchymal transition and
arresting G2/M phase in non-small cell lung cancer. Int J Oncol.
50:1251–1260. 2017.PubMed/NCBI
|
|
24
|
Ye Z, Zhang X, Luo Y, Li S, Huang L, Li Z,
Li P and Chen G: Prognostic values of Vimentin expression and its
clinicopathological significance in non-small cell lung cancer: A
meta-analysis of observational studies with 4118 cases. PLoS One.
11:e01631622016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong Z, Xia Y, Wang P, Liu B and Chen Y:
Low expression of microRNA-30c promotes invasion by inducing
epithelial mesenchymal transition in non-small cell lung cancer.
Mol Med Rep. 10:2575–2579. 2014.PubMed/NCBI
|
|
26
|
Nitsche U, Stangel D, Pan Z, Schlitter AM,
Esposito I, Regel I, Raulefs S, Friess H, Kleeff J and Erkan M:
Periostin and tumor-stroma interactions in non-small cell lung
cancer. Oncol Lett. 12:3804–3810. 2016.PubMed/NCBI
|
|
27
|
Moss LA Shuman and Stetler-Stevenson WG:
Influence of stromal components on lung cancer carcinogenesis. J
Carcinog Mutagen. 13:2013.doi: 10.4172/2157-2518.S13-008.
|
|
28
|
Zhang T, Xu J, Shen H, Dong W, Ni Y and Du
J: Tumor-stroma ratio is an independent predictor for survival in
NSCLC. Int J Clin Exp Pathol. 8:11348–11355. 2015.PubMed/NCBI
|
|
29
|
Donnem T, Al-Saad S, Al-Shibli K,
Delghandi MP, Persson M, Nilsen MN, Busund LT and Bremnes RM:
Inverse prognostic impact of angiogenic marker expression in tumor
cells versus stromal cells in non small cell lung cancer. Clin
Cancer Res. 13:6649–6657. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sulzer MA, Leers MP, van Noord JA, Bollen
EC and Theunissen PH: Reduced E-cadherin expression is associated
with increased lymph node metastasis and unfavorable prognosis in
non-small cell lung cancer. Am J Respir Crit Care Med.
157:1319–1323. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shibanuma H, Hirano T, Tsuji K, Wu Q,
Shrestha B, Konaka C, Ebihara Y and Kato H: Influence of E-cadherin
dysfunction upon local invasion and metastasis in non-small cell
lung cancer. Lung Cancer. 22:85–95. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu D, Huang C, Kameyama K, Hayashi E,
Yamauchi A, Kobayashi S and Yokomise H: E-cadherin expression
associated with differentiation and prognosis in patients with
non-small cell lung cancer. Ann Thorac Surg. 71:949–955. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moersig W, Horn S, Hilker M, Mayer E and
Oelert H: Transfection of E-cadherin cDNA in human lung tumor cells
reduces invasive potential of tumors. Thorac Cardiovasc Surg.
50:45–48. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Asnaghi L, Vass WC, Quadri R, Day PM, Qian
X, Braverman R, Papageorge AG and Lowy DR: E-cadherin negatively
regulates neoplastic growth in non-small cell lung cancer: Role of
Rho GTPases. Oncogene. 29:2760–2771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi Y, Wu H, Zhang M, Ding L, Meng F and
Fan X: Expression of the epithelial-mesenchymal transition-related
proteins and their clinical significance in lung adenocarcinoma.
Diagn Pathol. 8:892013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dauphin M, Barbe C, Lemaire S,
Nawrocki-Raby B, Lagonotte E, Delepine G, Birembaut P, Gilles C and
Polette M: Vimentin expression predicts the occurrence of
metastases in non small cell lung carcinomas. Lung Cancer.
81:117–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tadokoro A, Kanaji N, Liu D, Yokomise H,
Haba R, Ishii T, Takagi T, Watanabe N, Kita N, Kadowaki N and
Bandoh S: Vimentin regulates invasiveness and is a poor prognostic
marker in non-small cell lung cancer. Anticancer Res. 36:1545–1551.
2016.PubMed/NCBI
|
|
39
|
Havel LS, Kline ER, Salgueiro AM and
Marcus AI: Vimentin regulates lung cancer cell adhesion through a
VAV2-Rac1 pathway to control focal adhesion kinase activity.
Oncogene. 34:1979–1990. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rojiani MV, Alidina J, Esposito N and
Rojiani AM: Expression of MMP-2 correlates with increased
angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp
Pathol. 3:775–781. 2010.PubMed/NCBI
|
|
41
|
Qian Z, Zhao X, Jiang M, Jia W, Zhang C,
Wang Y, Li B and Yue W: Downregulation of cyclophilin A by siRNA
diminishes non-small cell lung cancer cell growth and metastasis
via the regulation of matrix metallopeptidase 9. BMC Cancer:.
12:4422012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He H, Zheng L, Sun YP, Zhang GW and Yue
ZG: Steroidal saponins from Paris polyphylla suppress adhesion,
migration and invasion of human lung cancer A549 cells via
down-regulating MMP-2 and MMP-9. Asian Pac J Cancer Prev.
15:10911–10916. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qian Q, Wang Q, Zhan P, Peng L, Wei SZ,
Shi Y and Song Y: The role of matrix metalloproteinase 2 on the
survival of patients with non-small cell lung cancer: A systematic
review with meta-analysis. Cancer Invest. 28:661–669. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Wang H, Ke H and Ni S: MiR-129
regulates MMP9 to control metastasis of non-small cell lung cancer.
Tumour Biol. 36:5785–5790. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yanagawa J, Walser TC, Zhu LX, Hong L,
Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, et al:
Snail promotes CXCR2 ligand-dependent tumor progression in
non-small cell lung carcinoma. Clin Cancer Res. 15:6820–6829. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu J, Hu G, Chen D, Gong AY, Soori GS,
Dobleman TJ and Chen XM: Suppression of SCARA5 by Snail1 is
essential for EMT-associated cell migration of A549 cells.
Oncogenesis. 2:e732013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu CW, Li CH, Peng YJ, Cheng YW, Chen HW,
Liao PL, Kang JJ and Yeng MH: Snail regulates Nanog status during
the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β
signaling pathway in non-small-cell lung cancer. Oncotarget.
5:3880–3894. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Merikallio H, Turpeenniemi-Hujanen T,
Pääkkö P, Mäkitaro R, Riitta K, Salo S, Salo T, Harju T and Soini
Y: Snail promotes an invasive phenotype in lung carcinoma. Respir
Res. 13:1042012. View Article : Google Scholar : PubMed/NCBI
|
